HIV Vaccines: Moving from Trials and Errors to Rational Design
Richard A. Koup, MD
Chief, Immunology Laboratory
Deputy Director, Vaccine Research Center
National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2016. All rights reserved.
Richard Koup is a Senior Investigator, Chief of the Immunology Laboratory, and Deputy Director of the Vaccine Research Center (VRC) within the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. Dr. Koup has spent most of his career studying the protective role of HIV-specific cellular immunity. His specific research involves the characterization of T and B cell factors that are involved in protective immunity against HIV infection, in order to inform the development of vaccines against HIV. He has published over 270 invited and/or peer-reviewed manuscripts on this and related topics, and has mentored 35 graduate and post-graduate students in his career. He serves as an Editor for PLoS Pathogens and on the editorial boards of several other scientific journals.
At the completion of this educational session, learners will:
- Appreciate the importance of the HIV vaccine effort as part of a comprehensive prevention strategy.
- Know the history and future prospects for developing an HIV vaccine.
- Be aware of the challenges still facing HIV vaccine development.
- Have a better understanding of the immunologic strategies being employed, and the potential pitfalls of each.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
